Lexagene Holdings (CVE: LXG- OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive with news the company has sold one of their MiQLab™ systems to Ethos Discovery. Regan telling Proactive Ethos Discovery, which has animal hospitals nationwide, will use the unit for the identification of pathogens and whether they are resistant to common therapies, which will allow veterinarians to make evidence-based patient care decisions much quicker.
Lexagene’s gets purchase order for rapid pathogen detection systems, MiQLab
Quick facts: LexaGene Holdings Inc.
Price: 0.99 CAD
Market Cap: $113.22 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE